• 1
    Ehrmann, D.A., Sturis, J., Byrne, M.M. et al. (1995) Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non-insulin dependent diabetes mellitus. The Journal of Clinical Investigation, 96, 520527.
  • 2
    Dunaif, A. (1997) Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocrine Reviews, 18, 774800.
  • 3
    Morgan, C., Jenkins-Jones, S., Currie, C. et al. (2012) Evaluation of adverse outcome in young women with polycystic ovary syndrome versus matched, reference controls: a retrospective, observational study. Journal of Clinical Endocrinology and Metabolism, [Epub ahead of print].
  • 4
    Talbott, E., Guzick, D., Clerici, A. et al. (1995) Coronary heart disease risk factors in women with polycystic ovary syndrome. Arteriosclerosis, Thrombosis, and Vascular Biology, 15, 821826.
  • 5
    Sampson, M., Kong, C., Patel, A. et al. (1996) Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome. Clinical Endocrinology (Oxford), 45, 623629.
  • 6
    Paradisi, G., Steinberg, H.O., Hempfling, A. et al. (2001) Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation, 103, 14101415.
  • 7
    Talbott, E.O., Guzick, D.S., Sutton-Tyrrell, K. et al. (2000) Evidence for the association between polycystic ovary syndrome and premature carotid atherosclerosis in middle aged women. Arteriosclerosis, Thrombosis, and Vascular Biology, 20, 24142421.
  • 8
    Esler, M., Lambert, G., Brunner-La Rocca, H.P. et al. (2003) Sympathetic nerve activity and neurotransmitter release in humans: translation from pathophysiology into clinical practice. Acta Physiologica Scandinavica, 177, 275284.
  • 9
    Axelrod, S., Gordon, D., Ubel, F.A. et al. (1981) Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science, 213, 220222.
  • 10
    Hagbarth, K.-E. & Vallbo, A.B. (1968) Pulse and respiratory grouping of sympathetic impulses in human muscle nerves. Acta Physiologica Scandinavica, 74, 98108.
  • 11
    Sundlof, G. & Wallin, B.G. (1977) The variability of muscle sympathetic nerve activity in resting recumbent man. The Journal of Physiology (London), 272, 383397.
  • 12
    Esler, M., Jennings, G., Korner, P. et al. (1984) Measurement of total and organspecific norepinephrine kinetics in humans. American Journal of Physiology, 247, E21E28.
  • 13
    Esler, M., Jennings, G., Leonard, P. et al. (1984) Contribution of individual organs to total noradrenaline release in humans. Acta Physiologica Scandinavica. Supplementum, 527, 1116.
  • 14
    La Rovere, M.T., Bigger J.T. Jr, Marcus, F.L. et al. (1998) Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction ATRAMI (Autonomic Tone and Reflexes after Myocardial Infarction) Investigators. Lancet, 351, 478484.
  • 15
    Narkiewicz, K., Winnicki, M., Schroeder, K. et al. (2002) Relationship between muscle sympathetic nerve activity and diurnal blood pressure profile. Hypertension, 39, 168172.
  • 16
    Hirsch, J. & MacKintosh, R.M. (2003) Measuring activity of the autonomic nervous system in humans. Obesity Research, 11, 24.
  • 17
    Grassi, G., Seravalle, G., Bolla, G. et al. (2008) Heart rate as a sympathetic marker during acute adrenergic challenge. Journal of Hypertension, 26, 7075.
  • 18
    Vallbo, A.B., Hagbarth, K.E., Torebjörk, H.E. et al. (1979) Somatosensory, proprioceptive and sympathetic activity in human peripheral nerves. Physiological Reviews, 59, 919957.
  • 19
    Macefield, V., Wallin, B.G. & Vallbo, A.B. (1994) The discharge behaviour of single vasoconstrictor motoneurones in human muscle nerves. The Journal of Physiology (London), 481, 799809.
  • 20
    Esler, M., Jennings, G., Korner, P. et al. (1988) The assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension, 11, 320.
  • 21
    Brown, G.L. & Gillespie, J.S. (1957) The output of sympathetic transmitter from the spleen of the cat. Journal of Physiology, 138, 81102.
  • 22
    Grassi, G. & Esler., M. (1999) How to assess sympathetic activity in humans. Journal of Hypertension, 17, 719734.
  • 23
    Alvarez, G.E., Beske, S.D., Ballard, T.P. et al. (2002) Sympathetic neural activation in visceral obesity. Circulation, 106, 25332536.
  • 24
    Grassi, G., Dell'Oro, R., Facchini, A. et al. (2004) Effect of central and peripheral body fat distribution on sympathetic and baroreflex function in obese normotensives. Journal of Hypertension, 22, 23632369.
  • 25
    Sivenius, K., Niskanen, L., Laakso, M. et al. (2003) A deletion in the α2β-adrenergic receptor gene and autonomic nervous function in central obesity. Obesity Research, 11, 962970.
  • 26
    Rumantir, M.S., Vaz, M., Jennings, G.L. et al. (1999) Neural mechanisms in human obesity-related hypertension. Journal of Hypertension, 17, 11251133.
  • 27
    Grassi, G., Dell-Oro, R., Quarti-Trevano, F. et al. (2005) Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia, 48, 13591365.
  • 28
    Huggett, R.J., Burns, J., Mackintosh, A.F. et al. (2004) Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension. Hypertension, 44, 847852.
  • 29
    Vaz, M., Jennings, G., Turner, A. et al. (1997) Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects. Circulation, 96, 34233429.
  • 30
    Smith, M.M. & Minson, C.T. (2012) Obesity and adipokines: effects on sympathetic overactivity. Journal of Physiology, 590, 17871801.
  • 31
    Arone, L.J., Mackintosh, R., Rosenbaum, M. et al. (1995) Autonomic nervous system activity in weight gain and weight loss. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 269, R222R225.
  • 32
    Young, J.B. & Landsberg, L. (1977) Suppression of sympathetic nervous system during fasting. Science, 196, 14731475.
  • 33
    Stephens, M., Ludgate, M. & Rees, D.A. (2011) Brown fat and obesity: the next big thing? Clinical Endocrinology (Oxford), 74, 661670.
  • 34
    Song, Y., Altarejos, J., Goodarzi, M.O. et al. (2010) CRTC3 links catecholamine signalling to energy balance. Nature, 468, 933939.
  • 35
    Mark, A.L., Agassandian, K., Morgan, D.A. et al. (2009) Leptin signaling in the nucleus tractus solitarii increases sympathetic nerve activity to the kidney. Hypertension, 53, 375380.
  • 36
    Grill, H.J. (2006) Distributed neural control of energy balance: contributions from hindbrain and hypothalamus. Obesity, 14, 216S221S.
  • 37
    Monroe, M.B., Van Pelt, R.E., Schiller, B.C. et al. (2000) Relation of leptin and insulin to adiposity associated elevations in sympathetic activity with age in humans. International Journal of Obesity and Related Metabolic Disorders, 24, 11831187.
  • 38
    Rahmouni, K., Haynes, W.G., Morgan, D.A. et al. (2002) Selective resistance to central neural administration of leptin in agouti obese mice. Hypertension, 39, 486490.
  • 39
    Rahmouni, K., Morgan, D.A., Morgan, G.M. et al. (2004) Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. The Journal of Clinical Investigation, 114, 652658.
  • 40
    Cassaglia, P., Hermes, S., Aicher, S. et al. (2011) Insulin actis in the arcuate nucleus to increase lumbar sympathetic nerve activity and baroreflex function in rats. Journal of Physiology, 589, 16431662.
  • 41
    Hopkins, D.F. & Williams, G. (1997) Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinity. Diabetic Medicine, 14, 10441050.
  • 42
    Dampney, R.A. (2011) Arcuate nucleus – a gateway for insulin's action on sympathetic activity. Journal of Physiology, 589, 21092110.
  • 43
    Vollenweider, P., Tappy, L., Randin, D. et al. (1993) Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans. The Journal of Clinical Investigation, 92, 147154.
  • 44
    Hausberg, M., Mark, A.L., Hoffman, R.P. et al. (1995) Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. Journal of Hypertension, 13, 10151021.
  • 45
    Young, C.N., Deo, S.H., Chaudhary, K. et al. (2010) Insulin enhances the gain of arterial baroreflex control of muscle sympathetic nerve activity in humans. Journal of Physiology, 588, 35933603.
  • 46
    Vollenweider, P., Randin, D., Tappy, L. et al. (1994) Impaired insulin-induced sympathetic neural activation and vasodilation in skeletal muscle in obese humans. The Journal of Clinical Investigation, 93, 23652371.
  • 47
    Straznicky, N.E., Lambert, G.W., Masuo, K. et al. (2009) Blunted sympathetic neural response to oral glucose in obese subjects with the insulin-resistant metabolic syndrome. American Journal of Clinical Nutrition, 89, 2736.
  • 48
    Landsberg, L. (1986) Diet, obesity and hypertension: an hypothesis involving insulin, the sympathetic nervous system, and adaptive thermogenesis. The Quarterly Journal of Medicine, 236, 10811090.
  • 49
    Masuo, K., Kawaguchi, H., Mikami, H. et al. (2003) Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension, 42, 474480.
  • 50
    Flaa, A., Aksnes, T.A., Kjeldsen, S.E. et al. (2008) Increased sympathetic reactivity may predict insulin resistance: an 18-year follow-up study. Metabolism, 57, 14221427.
  • 51
    Jamerson, K.A., Julius, S., Gudbrandsson, T. et al. (1993) Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension, 21, 618623.
  • 52
    Lembo, G., Capaldo, B., Rendina, V. et al. (1994) Acute noradrenergic activation induces insulin resistance in human skeletal muscle. American Journal of Physiology, 266, E242E247.
  • 53
    Fogel, R.B., Malhotra, A., Pillar, G. et al. (2001) Increased prevalence of obstructive sleep apnea syndrome in obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 86, 11751180.
  • 54
    Vgontzas, A.N., Legro, R.S., Bixler, E.O. et al. (2001) Polycystic ovary syndrome is associated with obstructive sleep apnea and daytime sleepiness: role of insulin resistance. Journal of Clinical Endocrinology and Metabolism, 86, 517520.
  • 55
    Gopal, M., Duntley, S., Uhles, M. et al. (2002) The role of obesity in the increased prevalence of obstructive sleep apnea syndrome in patients with polycystic ovary syndrome. Sleep Medicine, 3, 401404.
  • 56
    Tasali, E., Van Cauter, E., Hoffman, L. et al. (2008) Impact of obstructive sleep apnea on insulin resistance and glucose tolerance in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 93, 38783884.
  • 57
    Grassi, G., Facchini, A., Trevano, F.Q. et al. (2005) Obstructive sleep apnea-dependent and –independent adrenergic activation in obesity. Hypertension, 46, 321325.
  • 58
    Narkiewicz, K., Montano, N., Cogliati, C. et al. (1998) Altered cardiovascular variability in obstructive sleep apnea. Circulation, 98, 10711077.
  • 59
    Hedner, J., Darpö, B., Ejnell, H. et al. (1995) Reduction in sympathetic activity after long-term CPAP treatment in sleep apnoea: cardiovascular implications. European Respiratory Journal, 8, 222229.
  • 60
    Stener-Victorin, E., Ploj, K., Larsson, B.-M. et al. (2005) Rats with steroid-induced polycystic ovaries develop hypertension and increased sympathetic nervous system activity. Reproductive Biology and Endocrinology, 3, 44.
  • 61
    Luza, S.M., Lizama, L., Burgos, R.A. et al. (1995) Hypothalamic changes in norepinephrine release in rats with estradiol valerate-induced polycystic ovaries. Biology of Reproduction, 52, 398404.
  • 62
    Lara, H.E., Ferruz, J.L., Luza, S. et al. (1993) Activation of ovarian sympathetic nerves in polycystic ovary syndrome. Endocrinology, 133, 26902695.
  • 63
    Barria, A., Leyton, V., Ojeda, S.R. et al. (1993) Ovarian steroidal response to gonadotropins and beta-adrenergic stimulation is enhanced in polycystic ovary syndrome: role of sympathetic innervation. Endocrinology, 133, 26962703.
  • 64
    Lara, H.E., Dissen, G.A., Leyton, V. et al. (2000) An increased intraovarian synthesis of nerve growth factor and its low affinity receptor is a principal component of steroid-induced polycystic ovary in the rat. Endocrinology, 141, 10591072.
  • 65
    Dissen, G.A., Lara, H.E., Leyton, V. et al. (2000) Intraovarian excess of nerve growth factor increases androgen secretion and disrupts estrous cyclicity in the rat. Endocrinology, 141, 10731082.
  • 66
    Stener-Victorin, E., Lundeberg, T., Waldenström, U. et al. (2000) Effects of electro-acupuncture on nerve growth factor and ovarian morphology in rats with experimentally induced polycystic ovaries. Biology of Reproduction, 63, 14971503.
  • 67
    Manni, L., Lundeberg, T., Holmäng, A. et al. (2005) Effect of electro-acupuncture on ovarian expression of alpha(1)- and beta(2)-adrenoceptors, and p75 neurotrophin receptors in rats with steroid-induced polycystic ovaries. Reproductive Biology and Endocrinology, 3, 21.
  • 68
    Dissen, G.A., Garcia-Ruda, C., Paredes, A. et al. (2009) Excessive ovarian production of nerve growth factor facilitates development of cystic ovarian morphology in mice and is a feature of polycystic ovarian syndrome in humans. Endocrinology, 150, 29062914.
  • 69
    Heider, U., Pedal, I. & Spanel-Borowski, K. (2001) Increase in nerve fibers and loss of mast cells in polycystic and postmenopausal ovaries. Fertility Sterility, 75, 11411147.
  • 70
    Shoupe, D. & Lobo, R.A. (1984) Evidence for altered catecholamine metabolism in polycystic ovary syndrome. American Journal of Obstetric and Gynecology, 150, 536554.
  • 71
    Paradisi, R., Grossi, G., Venturoli, S. et al. (1989) Evidence for a hypothalamic alteration of catecholamine metabolism in polycystic ovary syndrome. Clinical Endocrinology (Oxford), 29, 317326.
  • 72
    Yoshino, K., Takashashi, K., Nishigaki, K. et al. (1992) Further evidence concerning catecholamine metabolism in polycystic ovary syndrome following GnRH administration. International Journal of Fertility, 37, 111114.
  • 73
    Garcia-Rudaz, C., Armando, I., Levin, G. et al. (1998) Peripheral catecholamine alterations in adolescents with polycystic ovary syndrome. Clinical Endocrinology (Oxford), 49, 221228.
  • 74
    Yildirir, A., Aybar, F., Kabakci, G. et al. (2006) Heart rate variability in young women with polycystic ovary syndrome. Annals of Noninvasive Electrocardiology, 11, 306312.
  • 75
    Tekin, G., Tekin, A., Kiliçarslan, E.B. et al. (2008) Altered autonomic neural control of the cardiovascular system in polycystic ovary syndrome. International Journal of Cardiology, 130, 4955.
  • 76
    Giallauria, F., Palomba, S., Cascella, T. et al. (2008) Abnormal heart rate recovery after maximal cardiopulmonary exercise stress testing in young overweight women with polycystic ovary syndrome. Clinical Endocrinology, 68, 8893.
  • 77
    Giallauria, F., Palomba, S., Maresca, L. et al. (2008) Exercise training improves autonomic function and inflammatory pattern in women with polycystic ovary syndrome (PCOS). Clinical Endocrinology, 69, 792798.
  • 78
    Sverrisdóttir, Y.B., Mogren, T., Kataoka, J. et al. (2008) Is polycystic ovary syndrome associated with high sympathetic nerve activity and size at birth? American Journal of Physiology, Endocrinology and Metabolism, 294, E576E581.
  • 79
    Straznicky, N.E., Grima, M.T., Eikelis, N. et al. (2011) The effects of weight loss versus weight loss maintenance on sympathetic nervous system activity and metabolic syndrome components. Journal of Clinical Endocrinology and Metabolism, 96, E503E508.
  • 80
    Straznicky, N.E., Lambert, E.A., Nestel, P.J. et al. (2010) Sympathetic neural adaptation to hypocaloric diet with or without exercise training in obese metabolic syndrome subjects. Diabetes, 59, 7179.
  • 81
    Palomba, S., Falbo, A., Zullo, F. et al. (2009) Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review. Endocrine Reviews, 30, 150.
  • 82
    Petersen, J.S. & DiBona, G.F. (1996) Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats. Hypertension, 27, 619625.
  • 83
    Gudbjornsdottir, S., Friberg, P., Elam, M. et al. (1994) The effect of metformin and insulin on sympathetic nerve activity, norepinephrine spillover and blood pressure in obese, insulin resistant, normoglycemic, hypertensive men. Blood Pressure, 3, 394403.
  • 84
    Yosefy, C., Magen, E., Kiselevich, A. et al. (2004) Rosiglitazone improves, while Glibenclamide worsens blood pressure control in treated hypertensive diabetic and dyslipidemic subjects via modulation of insulin resistance and sympathetic activity. Journal of Cardiovascular Pharmacology, 44, 215222.
  • 85
    Kobayashi, D., Takamura, M., Murai, H. et al. (2010) Effect of pioglitazone on muscle sympathetic nerve activity in type 2 diabetes mellitus with α-glucosidase inhibitor. Autonomic Neuroscience, 158, 8691.
  • 86
    Kaaja, R.J. & Pöyhönen-Alho, M.K. (2006) Insulin resistance and sympathetic overactivity in women. Journal of Hypertension, 24, 131141.
  • 87
    Stener-Victorin, E., Jedel, E., Janson, P.O. et al. (2009) Low-frequency electroacupuncture and physical exercise decrease high muscle sympathetic nerve activity in polycystic ovary syndrome. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 297, R387R395.
  • 88
    Jedel, E., Labrie, F., Odén, A. et al. (2011) Impact of electro-acupuncture and physical exercise on hyperandrogenism and olig/amenorrhea in women with polycystic ovary syndrome: a randomized controlled trial. American Journal of Physiology, Endocrinology and Metabolism, 300, E37E45.
  • 89
    Tasali, E., Chapotot, F., Leproult, R. et al. (2011) Treatment of obstructive sleep apnea improves cardiometabolic function in young obese women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 96, 365374.
  • 90
    Schlaich, M.P., Sobotka, P.A., Krum, H. et al. (2009) Renal sympathetic-nerve ablation for uncontrolled hypertension. New England Journal of Medicine, 361, 932934.
  • 91
    Krum, H., Schlaich, M., Whitbourn, R. et al. (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet, 373, 12751281.
  • 92
    Mahfoud, F., Schlaich, M., Kindermann, I. et al. (2011) Effect of renal sympathetic denervation on glucose metabolism in patients with resistant hypertension: a pilot study. Circulation, 123, 19401946.
  • 93
    Schlaich, M.P., Straznicky, N., Grima, M. et al. (2011) Renal denervation: a potential new treatment modality for polycystic ovary syndrome? Journal of Hypertension, 29, 991996.
  • 94
    Bisognano, J.D., Bakris, G., Nadim, M.K. et al. (2011) Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled Rheos Pivotal Trial. Journal of the American College of Cardiology, 58, 765773.